6550--Blood Type IVD Reagents
Closed Pre-Solicitation Posted
- Solicitation number
- 36C26226Q0599
- Agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Visn 22 Sites
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Department of Veterans Affairs Veterans Integrated Service Network 22 intends to solicit FDA-approved blood type in vitro diagnostic (IVD) reagents and consumables via an indefinite-delivery-indefinite-quantity (IDIQ) contract with responses to a Request for Information due May 20, 2026. No set-aside is anticipated.
Performance spans seven VA facilities within VISN 22: Phoenix VA Health Care System, New Mexico VA Healthcare System, Southern Arizona VA Health Care System, Long Beach VA Healthcare System, VA Greater Los Angeles, VA Loma Linda, VA San Diego, and VA Prescott.
Supplies must be AABB-accredited and CAP-accredited, with validation by VISN 22 Pathology and Laboratory Medicine Services (PALMS). Required products include ABO back-typing cells, complement check cells, IgG check cells, LISS, anti-sera across multiple blood group systems, elution kits, PEG, competency testing kits, and antibody identification panels containing at least 30 unique donor cells with antigen profiles determined by DNA analysis. The contractor must be the manufacturer of record, maintaining factory production lines and replacement consumables stock. Delivery is bi-monthly, Monday–Friday, 8 a.m.–4 p.m., with F.O.B. destination pricing and vendor-paid shipping. The vendor must reimburse the facility for referral laboratory testing costs when products are unavailable due to reagent or product problems.
The contract begins September 1, 2026, with a base year plus four one-year option periods through August 31, 2031. NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) applies, with a small business size standard of 1,250 employees. Respondents must provide detailed capabilities statements, SAM.gov registration, manufacturer or distributor status, U.S. manufacturing details with minimum 55 percent U.S. content, and existing federal contract vehicle availability. Responses to the RFI (36C26226Q0599) should address Marcos Diaz at Marcos.Diaz@va.gov by May 20 at 7:00 a.m. Pacific Time.
Notice text
See attachments:
Files
| File | Type | Posted |
|---|---|---|
| P02 - RFI Attachment B SOW.pdf | ||
| P02 - RFI 36C26226Q0599 Reagents.pdf | ||
| 36C26226Q0599.docx | DOCX document | |
| P02 - RFI Attachment A.xlsx | XLSX spreadsheet |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--VA Boise, Idaho - Blood Bank Reagents Requirement | Veterans Integrated Service Network 20 | No set-aside | |
| 6550--VISN 4 Coagulation Testing | Veterans Integrated Service Network 4 | No set-aside | |
| 6550--hemochron signature elite reagents and supplies | Veterans Integrated Service Network 22 | No set-aside | |
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside | |
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity